Triggering Ovulation at Follicle Size Smaller or Larger Than 17mm in a Modified Natural Cycle

Recruiting N/A Interventional Study
Embryo Transfer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
572 (estimated)
Sponsor
Vida Recoletas Sevilla · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The rise in frozen embryo transfer (FET) cycles within assisted reproductive technology (ART) has sparked the need to refine endometrial preparation protocols. The switch from hormone replacement cycles (HRT) to natural cycles, poses scheduling challenges onto laboratories, doctors and patients. The modified natural cycle (mNC), offering more precision for scheduling, shows promise but lacks compr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * At least one expanded blastocyst (regardless of its quality) * Spontaneous menstrual cycles * Consent to undergo frozen embryo transfer in a modified natural cycle Exclusion Criteria: * Abnormal uterine cavity * Fluid in endometrial cavity
Contacts

Manuel Fernández Sánchez, MD PhD

+34954286274

vida.investiga@gruporecoletas.com

CONTACT

Clara Palacio de Marco, MSc

+34954286274

clara.palacio@gruporecoletas.com

CONTACT